Abstract #2599
High Spatial Resolution Myocardial T 2 * Mapping at 7.0 T Reveals Differences between Healthy Volunteers and Patients with Hypertrophic Cardiomyopathy
Till Huelnhagen 1 , Fabian Hezel 1 , Andreas Pohlmann 1 , Andreas Graessl 1 , Jan Rieger 2 , Darius Lysiak 2 , Christof Thalhammer 1 , Peter Kellman 3 , Marcel Prothmann 4 , Jeanette Schulz-Menger 4,5 , and Thoralf Niendorf 1,5
1
Berlin Ultrahigh Field Facility (B.U.F.F.),
Max-Delbrueck Center for Molecular Medicine (MDC),
Berlin, Germany,
2
MRI.TOOLS
GmbH, Berlin, Germany,
3
National
Heart, Lung, and Blood Institute, National Institutes of
Health, Bethesda, MD, United States,
4
Dept.
of Cardiology and Nephrology, HELIOS Klinikum
Berlin-Buch, Berlin, Germany,
5
Experimental
and Clinical Research Center, a joint cooperation
between the Charite Medical Faculty and the
Max-Delbrueck Center, Berlin, Germany
This work examines the capability of T
2
*
mapping
at 7.0 T to differentiate between normal myocardium and
myocardial tissue affected by hypertrophic
cardiomyopathy. This is the first patient study report
on cardiac MR at 7.0 T. Results show, that high spatial
resolution myocardial T
2
*
mapping
at 7.0 T reveals differences between healthy volunteers
and patients with hypertrophic cardiomyopathy. This
observation holds the promise to provide means for an MR
based biomarker for the risk stratification of HCM.
This abstract and the presentation materials are available to members only;
a login is required.
Join Here
